Search Result "insulin glargine plus lixisenatide"
Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the Literature
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 4 Year: 2021 Page: 626-646
Author(s): Giuseppe Lisco,Anna De Tullio,Edoardo Guastamacchia,Vincenzo Triggiani
Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review
Journal: Current Vascular Pharmacology
Volume: 11 Issue: 6 Year: 2013 Page: 992-1000
Author(s): Evangelos C. Rizos,Evangelia E. Ntzani,Nikolaos Papanas,Vasilis Tsimihodimos,Zoi Mitrogianni,Efstratios Maltezos,Moses S. Elisaf
Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Journal: Current Medicinal Chemistry
Volume: 25 Issue: 13 Year: 2018 Page: 1549-1566
Author(s): Ioanna Eleftheriadou,Pinelopi Grigoropoulou,Evangelos Liberopoulos,Stavros Liatis,Alexandros Kokkinos,Nikolaos Tentolouris
Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
Journal: Current Diabetes Reviews
Volume: 11 Issue: 1 Year: 2015 Page: 17-31
Author(s): Friedrich Mittermayer,Erica Caveney,Claudia De Oliveira,Loukas Gourgiotis,Mala Puri,Li-Jung Tai,J. Rick Turner
GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus
Journal: Current Diabetes Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 279-292
Author(s): Lalita Dahiya,Ramandeep Kaur,Rajiv Kumar,Manoj Kumar,Kezia Palta
Role of GLP-1 Receptor Agonist in Diabetic Cardio-renal Disorder:Recent Updates of Clinical and Pre-clinical Evidence
Journal: Current Diabetes Reviews
Volume: 20 Issue: 6 Year: 2024 Page: 44-57
Author(s): Surendra H. Bodakhe
Recent Trials on the Cardioprotective Effects of New Generation Anti-diabetic and Lipid-Lowering Agents
Ebook: Frontiers in Clinical Drug Research-Diabetes and Obesity
Volume: 7 Year: 2023
Author(s):
Doi: 10.2174/9789815123586123070008
Novel Approaches to the Management of Diabetes Mellitus in Patients withCoronary Artery Disease
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 23 Year: 2023 Page: 1844-1862
Author(s): George E. Zakynthinos,Maria I. Gounaridi
Glycemic Control and CKD: Evaluation of the Risk/Benefit Ratio: Optimal Therapeutic Strategies
Ebook: Diabetes: Current and Future Developments
Volume: 1 Year: 2020
Author(s): Gül Bahtiyar,Harold Lebovitz,Alan Sacerdote
Doi: 10.2174/9789811422003120010014